The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides

被引:209
作者
Far, RKK [1 ]
Sczakiel, G [1 ]
机构
[1] Univ Lubeck, Inst Mol Med, D-23538 Lubeck, Germany
关键词
D O I
10.1093/nar/gkg649
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biological activity of siRNA seems to be influenced by local characteristics of the target RNA, including local RNA folding. Here, we investigated quantitatively the relationship between local target accessibility and the extent of inhibition of the target gene by siRNA. Target accessibility was assessed by a computational approach that had been shown earlier to be consistent with experimental probing of target RNA. Two sites of ICAM-1 mRNA predicted to serve as accessible motifs and one site predicted to adopt an inaccessible structure were chosen to test siRNA constructs for suppression of ICAM-1 gene expression in ECV304 cells. The local target-dependent effectiveness of siRNA was compared with antisense oligonucleotides (asON). The concentration dependency of siRNA-mediated suppression indicates a >1000-fold difference between active siRNAs (IC50 approximate to 0.2-0.5 nM) versus an inactive siRNA (IC50 greater than or equal to 1 muM) which is consistent with the activity pattern of asON when relating target suppression to predicted local target accessibility. The extremely high activity of the siRNA si2B (IC50 = 0.24 nM) indicates that not all siRNAs shown to be active at the usual concentrations of >10-100 nM belong to this highly active species. The observations described here suggest an option to assess target accessibility for siRNA and, thus, support the design of active siRNA constructs. This approach can be automated, work at high throughput and is open to include additional parameters relevant to the biological activity of siRNA.
引用
收藏
页码:4417 / 4424
页数:8
相关论文
共 32 条
[1]   Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes [J].
Amarzguioui, M ;
Brede, G ;
Babaie, E ;
Grotli, M ;
Sproat, B ;
Prydz, H .
NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4113-4124
[2]   The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript [J].
Bohula, EA ;
Salisbury, AJ ;
Sohail, M ;
Playford, MP ;
Riedemann, J ;
Southern, EM ;
Macaulay, VM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15991-15997
[3]   HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture [J].
Bramlage, B ;
Luzi, E ;
Eckstein, F .
NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4059-4067
[4]  
CHIANG MY, 1991, J BIOL CHEM, V266, P18162
[5]  
Dirks WG, 1999, IN VITRO CELL DEV-AN, V35, P558
[6]  
DIRKS WG, 2000, IN VITRO CELL DEV, V5, P194
[7]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[8]   Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate [J].
Elbashir, SM ;
Martinez, J ;
Patkaniowska, A ;
Lendeckel, W ;
Tuschl, T .
EMBO JOURNAL, 2001, 20 (23) :6877-6888
[9]  
Far RKK, 2001, BIOINFORMATICS, V17, P1058
[10]   Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs [J].
Hamada, M ;
Ohtsuka, T ;
Kawaida, R ;
Koizumi, M ;
Morita, K ;
Furukawa, H ;
Imanishi, T ;
Miyagishi, M ;
Taira, K .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2002, 12 (05) :301-309